IDO1 and hepatocellular carcinoma: Indoleamine 2,3-dioxygenase (IDO) is an intracellular enzyme involved in the rate limiting step of the catabolism of tryptophan to kynurenine, which is expressed by multiple human malignancies, including HCC [18, 19].